Cargando…
Visual Detection of Human Antibodies Using Sugar Chain-Immobilized Fluorescent Nanoparticles: Application as a Point of Care Diagnostic Tool for Guillain-Barré Syndrome
Sugar chain binding antibodies have gained substantial attention as biomarkers due to their crucial roles in various disorders. In this study, we developed simple and quick detection method of anti-sugar chain antibodies in sera using our previously developed sugar chain-immobilized fluorescent nano...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574945/ https://www.ncbi.nlm.nih.gov/pubmed/26378448 http://dx.doi.org/10.1371/journal.pone.0137966 |
_version_ | 1782390695467679744 |
---|---|
author | Shinchi, Hiroyuki Yuki, Nobuhiro Ishida, Hideharu Hirata, Koichi Wakao, Masahiro Suda, Yasuo |
author_facet | Shinchi, Hiroyuki Yuki, Nobuhiro Ishida, Hideharu Hirata, Koichi Wakao, Masahiro Suda, Yasuo |
author_sort | Shinchi, Hiroyuki |
collection | PubMed |
description | Sugar chain binding antibodies have gained substantial attention as biomarkers due to their crucial roles in various disorders. In this study, we developed simple and quick detection method of anti-sugar chain antibodies in sera using our previously developed sugar chain-immobilized fluorescent nanoparticles (SFNPs) for the point-of-care diagnostics. Sugar chain structure on SFNPs was modified with the sugar moieties of the GM1 ganglioside via our original linker molecule to detect anti-GM1 antibodies. The structures and densities of the sugar moieties immobilized on the nanoparticles were evaluated in detail using lectins and sera containing anti-GM1 antibodies from patients with Guillain-Barré syndrome, a neurological disorder, as an example of disease involving anti-sugar chain antibodies. When optimized SFNPs were added to sera from patients with Guillain-Barré syndrome, fluorescent aggregates were able to visually detect under UV light in three hours. The sensitivity of the detection method was equivalent to that of the current ELISA method used for the diagnosis of Guillain-Barré syndrome. These results suggest that our method using SFNPs is suitable for the point-of-care diagnostics of diseases involving anti-sugar chain antibodies. |
format | Online Article Text |
id | pubmed-4574945 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-45749452015-09-25 Visual Detection of Human Antibodies Using Sugar Chain-Immobilized Fluorescent Nanoparticles: Application as a Point of Care Diagnostic Tool for Guillain-Barré Syndrome Shinchi, Hiroyuki Yuki, Nobuhiro Ishida, Hideharu Hirata, Koichi Wakao, Masahiro Suda, Yasuo PLoS One Research Article Sugar chain binding antibodies have gained substantial attention as biomarkers due to their crucial roles in various disorders. In this study, we developed simple and quick detection method of anti-sugar chain antibodies in sera using our previously developed sugar chain-immobilized fluorescent nanoparticles (SFNPs) for the point-of-care diagnostics. Sugar chain structure on SFNPs was modified with the sugar moieties of the GM1 ganglioside via our original linker molecule to detect anti-GM1 antibodies. The structures and densities of the sugar moieties immobilized on the nanoparticles were evaluated in detail using lectins and sera containing anti-GM1 antibodies from patients with Guillain-Barré syndrome, a neurological disorder, as an example of disease involving anti-sugar chain antibodies. When optimized SFNPs were added to sera from patients with Guillain-Barré syndrome, fluorescent aggregates were able to visually detect under UV light in three hours. The sensitivity of the detection method was equivalent to that of the current ELISA method used for the diagnosis of Guillain-Barré syndrome. These results suggest that our method using SFNPs is suitable for the point-of-care diagnostics of diseases involving anti-sugar chain antibodies. Public Library of Science 2015-09-17 /pmc/articles/PMC4574945/ /pubmed/26378448 http://dx.doi.org/10.1371/journal.pone.0137966 Text en © 2015 Shinchi et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Shinchi, Hiroyuki Yuki, Nobuhiro Ishida, Hideharu Hirata, Koichi Wakao, Masahiro Suda, Yasuo Visual Detection of Human Antibodies Using Sugar Chain-Immobilized Fluorescent Nanoparticles: Application as a Point of Care Diagnostic Tool for Guillain-Barré Syndrome |
title | Visual Detection of Human Antibodies Using Sugar Chain-Immobilized Fluorescent Nanoparticles: Application as a Point of Care Diagnostic Tool for Guillain-Barré Syndrome |
title_full | Visual Detection of Human Antibodies Using Sugar Chain-Immobilized Fluorescent Nanoparticles: Application as a Point of Care Diagnostic Tool for Guillain-Barré Syndrome |
title_fullStr | Visual Detection of Human Antibodies Using Sugar Chain-Immobilized Fluorescent Nanoparticles: Application as a Point of Care Diagnostic Tool for Guillain-Barré Syndrome |
title_full_unstemmed | Visual Detection of Human Antibodies Using Sugar Chain-Immobilized Fluorescent Nanoparticles: Application as a Point of Care Diagnostic Tool for Guillain-Barré Syndrome |
title_short | Visual Detection of Human Antibodies Using Sugar Chain-Immobilized Fluorescent Nanoparticles: Application as a Point of Care Diagnostic Tool for Guillain-Barré Syndrome |
title_sort | visual detection of human antibodies using sugar chain-immobilized fluorescent nanoparticles: application as a point of care diagnostic tool for guillain-barré syndrome |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574945/ https://www.ncbi.nlm.nih.gov/pubmed/26378448 http://dx.doi.org/10.1371/journal.pone.0137966 |
work_keys_str_mv | AT shinchihiroyuki visualdetectionofhumanantibodiesusingsugarchainimmobilizedfluorescentnanoparticlesapplicationasapointofcarediagnostictoolforguillainbarresyndrome AT yukinobuhiro visualdetectionofhumanantibodiesusingsugarchainimmobilizedfluorescentnanoparticlesapplicationasapointofcarediagnostictoolforguillainbarresyndrome AT ishidahideharu visualdetectionofhumanantibodiesusingsugarchainimmobilizedfluorescentnanoparticlesapplicationasapointofcarediagnostictoolforguillainbarresyndrome AT hiratakoichi visualdetectionofhumanantibodiesusingsugarchainimmobilizedfluorescentnanoparticlesapplicationasapointofcarediagnostictoolforguillainbarresyndrome AT wakaomasahiro visualdetectionofhumanantibodiesusingsugarchainimmobilizedfluorescentnanoparticlesapplicationasapointofcarediagnostictoolforguillainbarresyndrome AT sudayasuo visualdetectionofhumanantibodiesusingsugarchainimmobilizedfluorescentnanoparticlesapplicationasapointofcarediagnostictoolforguillainbarresyndrome |